SC 13G Filing

Company

Traws Pharma, Inc.

Filed

May 7, 2018

Accession Number

0000935836-18-000274

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →